The effect of vitamin D on the glycemic control and non-alcoholic fatty liver disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000406

Enrollment

180

Registered

2012-04-17

Start date

2011-12-16

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Partipants will be randomized into two groups (intervention vs placebo) The number of participants will be 180. Participants will take Vitamin D 2000 IU or placebo for 24 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetic patients whose A1C between 6.5% and 8.4% or non-alcoholic fatty liver disease patients whose body mass index >23kg/m2

Exclusion criteria

Exclusion criteria: diabetic medication changed within 2 months vitamin D or Osteoporosis treatment Alcoholics Renal insufficiency (Male Cr>1.5, Female Cr>1.4) Viral hepatitis or Liver cirrhosis

Design outcomes

Primary

Measure	Time frame
HbA1C	—

Secondary

Measure	Time frame
Fatty liver by abdominal computed tomography	—

Countries

Korea, Republic of

Contacts

Public ContactOhk Hyun Ryu

Hallym University Medical Center- Chuncheon

Outcome results